Q1 2011 · —
Revenue$10.24M$10.24M +15.8% vs Q1 2010−39.0% vs Q4 2010
Net Income-$18.40M-$18.40M N/M vs Q1 2010N/M vs Q4 2010
EPS Diluted-$0.19-$0.19 N/M vs Q1 2010N/M vs Q4 2010
Operating Income-$18,542,000—
Operating Cash Flow-$23,913,000—
Free Cash Flowderived-$27,381,000—
Margins · derived
Operating margin-181.1%
Net margin-179.7%+4.1 pt vs Q1 2010
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenue | $10.24M | $8.84M |
| Net Income | -$18.40M | -$16.25M |
| EPS Diluted | -$0.19 | -$0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR